Evidence map›Paper›PMID 16049341›Full record

ArticleThe American journal of pathology2005

Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis.

Adam H Johnson, Henry F Frierson, Alexander Zaika, Steven M Powell, James Roche, Sheila Crowe, Christopher A Moskaluk, Wa'el El-Rifai

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The American journal of pathology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 111 citations in OpenAlex.

  1. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Food science & nutrition · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. World journal of gastroenterology · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Claudin proteins, outside-in signaling, and carcinogenesis.Pflugers Archiv : European journal of physiology · 2017
    Review
  17. Article
  18. Review
  19. Article
  20. Mouse models of gastric carcinogenesis.Journal of gastric cancer · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Adam H JohnsonDigestive Health Center of Excellence, University of Virginia Health System, P.O. Box 800708, Charlottesville, VA 22908-0708, USA.
Henry F Frierson
Alexander Zaika
Steven M Powell
James Roche
Sheila Crowe
Christopher A Moskaluk
Wa'el El-Rifai
University of Virginia Health System · US

Funding

Targets of Gene Overexpression at 17q in Gastric Tumorigenesis: Darpp32R01CA093999 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI EL-RIFAI, WAEL · 2002 to 2017
$4.5M
NCI NIH HHS CA93999NCI NIH HHS R01 CA093999
6 · The paper itself

Abstract

Trefoil factor-1 (Tff1) expression is remarkably down-regulated in nearly all human gastric cancers. Therefore, we used the Tff1 knockout mouse model to detect molecular changes in preneoplastic gastric dysplasia. Oligonucleotide microarray gene expression analysis of gastric dysplasia of Tff1-/- mice was compared to that of normal gastric mucosa of wild-type mice. The genes most overexpressed in Tff1-/- mice included claudin-7 (CLDN7), early growth response-1 (EGR1), and epithelial membrane protein-1 (EMP1). Quantitative real-time reverse transcriptase-polymerase chain reaction and immunohistochemistry showed that Cldn7 was overexpressed in all 10 Tff1-/- gastric dysplasia samples. Comparison with our serial analysis of gene expression database of human gastric cancer revealed similar deregulation in human gastric cancers. Quantitative real-time reverse transcriptase-polymerase chain reaction of human gastric adenocarcinoma samples indicated that, of these three genes, CLDN7 was the most frequently up-regulated gene. Using immunohistochemistry, both mouse and human gastric glands overexpressed Cldn7 in dysplastic but not surrounding normal glands. Cldn7 expression was observed in 30% of metaplasia, 80% of dysplasia, and 70% of gastric adenocarcinomas. Interestingly, 82% of human intestinal-type gastric adenocarcinomas expressed Cldn7 whereas diffuse-type gastric adenocarcinomas did not (P < 0.001). These results suggest that Cldn7 expression is an early event in gastric tumorigenesis that is maintained throughout tumor progression.

Indexed as

Gene Expression ProfilingAdenocarcinomaAgedAged, 80 and overAnimalsClaudinsDNA-Binding ProteinsEarly Growth Response Protein 1EstrogensFemaleGastric MucosaGrowth InhibitorsHumansImmediate-Early ProteinsMaleMembrane ProteinsClaudinsCLDN7 protein, humanDNA-Binding ProteinsEarly Growth Response Protein 1EGR1 protein, humanepithelial membrane protein-1EstrogensGrowth InhibitorsImmediate-Early ProteinsMembrane ProteinsNeoplasm ProteinsReceptors, Cell SurfaceTFF1 protein, humanTranscription FactorsTrefoil Factor-1Tumor Suppressor Proteins

Identifiers

PMID16049341
PMCPMC1603560
OpenAlexW2031279966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.